Friday July 3, 2020

AGI Therapeutics flotation to raise more than expected

AGI Therapeutics, the drug firm run by former Elan executives, will float on the Alternative Investment Market on February 27, raising stg£29.2 million (€42.7 million).

18th February, 2006

AGI Therapeutics, the drug firm run by former Elan executives, will float on the Alternative Investment Market on February 27, raising stg£29.2 million (€42.7 million).

The company is confident of raising more than its initial target of €35 million after strong demand for its shares at investor roadshows. AGI, which is less than three years old, is likely to be valued at over €120 million in the flotation.

AGI’s biggest individual shareholder is co-founder and...

Subscribe from just €1 for the first month!

Exclusive offers:

All Digital Access + eReader

Trial

€1

Unlimited Access for 1 Month

Then €19.99 a month after the offer period.

Get basic
*New subscribers only
You can cancel any time.

Annual

€200

€149 For the 1st Year

Unlimited Access for 1 Year

You can cancel any time.

Quarterly

€55

€42

90 Day Pass

You can cancel any time.

Team Pass

Get a Business Account for you and your team

Share this post

Related Stories

The best writing and and the biggest stories of 2019 from the Business Post

Richie Oakley | 6 months ago

Denis O’Brien is back in court, residents continue to fight the Council on halting site and a row surfaces in government over rent control proposals

Leanna Byrne | 4 years ago